Enhanced ERK activity extends ketamine’s antidepressant effects by augmenting synaptic plasticity
Science · 08.05.2025 · 388 (6747) · 646-655
DOI: 10.1126/science.abb6748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 08.05.2025. Verfasst von Z Zack Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Vanderbilt University, Nashville, TN, USA. Hauptthemen laut MEDLINE: Antidepressive Agents, Dual Specificity Phosphatase 6, Extracellular Signal-Regulated MAP Kinases, Ketamine. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Repeated ketamine treatment to maintain a rapid antidepressant effect can lead to side effects over time, highlighting an unmet clinical need for sustaining this drug’s antidepressant action from a single administration. Ketamine-induced synaptic potentiation at CA3-CA1 synapses has been proposed to be a key synaptic substrate for antidepressant action. Here, we found that ketamine-induced CA3-CA1 synaptic potentiation could be augmented by transiently increasing extracellular signal–regulated kinase (ERK) activity through pharmacological inhibition of dual-specificity phosphatases 6 (DUSP6). The antidepressant-like behavioral effects of acute ketamine treatment were extended by DUSP6 inhibition for up to 2 months. The selective deletion of tropomyosin receptor kinase B (TrkB) in excitatory neurons abolished these DUSP6 inhibition–mediated synaptic and behavioral effects. These data suggest that ketamine’s rapid antidepressant effects can be sustained by selectively targeting downstream intracellular signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.
- Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA.
ORCID-Profile: Z Zack Ma, Ji-Woon Kim, Ege T Kavalali, Lisa M Monteggia
Förderung
- NIMH NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- NICHD NIH HHS
Zitieren
APA
Ma, Z. Z., Guzikowski, N. J., Kim, J. W., Kavalali, E. T., & Monteggia, L. M. (2025). Enhanced ERK activity extends ketamine’s antidepressant effects by augmenting synaptic plasticity. Science, 388(6747), 646-655. https://doi.org/10.1126/science.abb6748
Vancouver
Ma ZZ, Guzikowski NJ, Kim JW, Kavalali ET, Monteggia LM. Enhanced ERK activity extends ketamine’s antidepressant effects by augmenting synaptic plasticity. Science. 2025;388(6747):646-655. doi:10.1126/science.abb6748
BibTeX
@article{Ma2025,
author = {Ma, Z Zack and Guzikowski, Natalie J and Kim, Ji-Woon and Kavalali, Ege T and Monteggia, Lisa M},
title = {Enhanced ERK activity extends ketamine’s antidepressant effects by augmenting synaptic plasticity},
journal = {Science},
year = {2025},
volume = {388},
number = {6747},
pages = {646--655},
doi = {10.1126/science.abb6748}
}
EUVIMED